CAS: 5061-22-3 - 1,1′-(1,4-Piperazinediyldi-2,1-ethanediyl) bis(α-methyl-1-naphthaleneacetate)
Formula:C34H38N2O4
InChI:InChI=1S/C34H38N2O4/c1-25(29-15-7-11-27-9-3-5-13-31(27)29)33(37)39-23-21-35-17-19-36(20-18-35)22-24-40-34(38)26(2)30-16-8-12-28-10-4-6-14-32(28)30/h3-16,25-26H,17-24H2,1-2H3
InChI key:InChIKey=ZLFQARCCMWUSQE-UHFFFAOYSA-N
SMILES:O=C(OCCN1CCN(CCOC(=O)C(C2=CC=CC=3C=CC=CC32)C)CC1)C(C4=CC=CC=5C=CC=CC54)C
| Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
|---|---|---|---|---|
 | Nafiverine REF: 3D-FN176221CAS: 5061-22-3 | Min. 95% | Prezzo su richiesta | Ven 13 Dic 24 |
 | Nafiverine REF: TM-T24517CAS: 5061-22-3 | 98% | 904,00 €~2.329,00 € | Mar 21 Gen 25 |
Nafiverine
CAS:5061-22-3
Nafiverine is a drug that is used to treat bladder cancer. It is administered as …
Purezza:
Min. 95%
Ref: 3D-FN176221
| Dimensione non definita | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Venerdì 13 Dicembre 2024
Nafiverine
CAS:5061-22-3
Nafiverine is a new antispasmodic. The effectiveness of an intramuscular administration of nafiverine was comparable …
Formula:
C34H38N2O4
Purezza:
98%
Colore e forma:
Solid
Peso molecolare:
538.68
Ref: TM-T24517
| 25mg | 1.410,00 € | ||
| 50mg | 1.845,00 € | ||
| 100mg | 2.329,00 € |
Consegna stimata in Stati Uniti, il Martedì 21 Gennaio 2025
